Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2023-10-01
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Toward a Real-time Access to Sleepers' Mental Content
NCT05452733
Neurobehavioral Effects of Partial Sleep Deprivation
NCT02128737
Does Acoustic Stimulation During Sleep Boost Slow Wave Sleep and Memory Performance?
NCT04277104
Acoustic Stimulation During Restricted Sleep After Sleep Deprivation
NCT05309473
Reactivating Specific Memories During Sleep in Conjunction with a Suppression Context
NCT04702750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The kinetics of cognitive performance degradation during acute sleep restriction or deprivation are relatively well studied in the literature2, with significant inter-individual variability. Restoring these cognitive functions requires sufficient sleep, sometimes for several days. However, the military work environment often offers only limited opportunities for recovery, which does not allow for ad integrum restoration of cognitive capacities, although some subjects recover better than others.
This is problematic in an environment where individual and collective performance levels are a prerequisite for safety and mission success3.
In this context, early identification of poor recuperators, who do not sufficiently restore their cognitive performance after periods of rest, would enable us to adapt more effectively the use of different countermeasures (sleep extension, naps, adapted use of caffeine...)4. This implies the availability of validated objective markers, as subjective assessments are often inadequate in this context. The temporal data classically derived from the analysis of sleep macrostructure (total sleep time, duration of wakefulness after falling asleep, time spent in the various sleep stages, etc.) are compromised when the opportunity for sleep is restricted. It therefore becomes pertinent to look for non-temporal markers that would testify to the efficiency of sleep's recuperative function.
Delta slow waves \[1 - 4 Hz\], which are mainly observed during deep slow-wave sleep on a sleep EEG, appear to be one of the indicators of the restorative function of sleep. They have been identified as a marker of sleep pressure5. The spectral power in this frequency range (delta power or slow-waves activity), obtained after fast Fourier transformation, bears witness to the activity of these waves. It is known to increase at the start of the night, particularly after sleep debt, and then gradually decrease, reflecting the dissipation of sleep pressure. It is recognized that high spectral power in this frequency range, particularly in deep slow wave sleep, is a marker of the "depth" of sleep" . This depth could guarantee the restorative function of sleep. \[...\]
In a laboratory protocol in healthy adults, exposed to a prolonged period of wakefulness with a restricted opportunity for sleep (40h of wakefulness / 3h of sleep / 21h of wakefulness), we hypothesize that the relative increase in spectral power of Delta waves \[ 1 - 4 Hz\] in NREM in the frontal territory, identified as a potential marker of the restorative function of sleep, during a night of sleep with limited recovery (3 h of time in bed) after sleep deprivation (40 h of continuous wakefulness), will be less important in subjects with poor recovery in terms of cognitive performance than in those with good recovery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep
Sleep deprivation
Sleep deprivatin
40 hours of continuous awakening
Sleep recovery
sleep recovery after 40 hours of continuous awakening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sleep deprivatin
40 hours of continuous awakening
Sleep recovery
sleep recovery after 40 hours of continuous awakening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18 and 45 years of age
* Having given written consent after having been informed of the terms of the study and the objectives of the genetic analysis performed
Exclusion Criteria
* Chronic medical pathology, (psychol, cardiovascular or respiratory, sleep disorders)
* Pregnancy
* Sleep disorder
* Extreme chronotype
* Excessive daytime sleepiness
* Suspicion of anxiety or depressive disorder
* Estimated caffeine consumption \> 200mg/day
* Not covered by a health insurance
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hotel Dieu de France Hospital
OTHER
University of Paris 5 - Rene Descartes
OTHER
Institut de Recherche Biomedicale des Armees
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de recherche biomédical des armées
Brétigny-sur-Orge, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01221-44
Identifier Type: OTHER
Identifier Source: secondary_id
2023_RECOPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.